Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

June 29, 2015 7:13 PM ET

Capital Markets

Company Overview of Sofinnova Ventures, Inc.

Company Overview

Sofinnova Ventures, Inc. is a venture capital firm specializing in seed, startup, early stage, series A, first venture round, and corporate spinouts. It also considers investments in intermediate and later stage startup companies. The firm does not invest in healthcare services, tool-kit companies, diagnostics, and neutraceuticals. It seeks to invest in life sciences and information technology sectors. In life sciences sector, it seeks to invest in clinical stage pharmaceutical products companies, biotechnology, therapeutic drug or product companies in the late preclinical or Phase I clinical stage, drug companies to treat diseases with unmet medical needs, drug discovery platform technology...

140 Geary Street

10th Floor

San Francisco, CA 94108

United States

Founded in 1974





Key Executives for Sofinnova Ventures, Inc.

Founding Partner
Founder and Managing Partner
Age: 39
Chief Financial Officer and Partner
General Partner, Managing Partner, and Partner
Age: 49
General Partner
Age: 59
Compensation as of Fiscal Year 2014.

Sofinnova Ventures, Inc. Key Developments

Sofinnova Ventures, Inc. Presents at Boston CEO Conference, May-26-2015 04:00 PM

Sofinnova Ventures, Inc. Presents at Boston CEO Conference, May-26-2015 04:00 PM. Venue: Four Seasons Hotel, 200 Boylston Street, Boston, MA 02116, United States. Speakers: Michael F. Powell, General Partner.

aTyr May Go For IPO

A big venture round led by Sofinnova Ventures, Inc. and backed by a lengthy string of biotech stalwarts and public investment firms is bound to get tongues wagging again about a possible IPO in the near future for aTyr Pharma Inc.

Sofinnova Ventures, Inc. Presents at Biocom's Global Life Science Partnering Conference, Feb-25-2015 03:30 PM

Sofinnova Ventures, Inc. Presents at Biocom's Global Life Science Partnering Conference, Feb-25-2015 03:30 PM. Venue: The Lodge at Torrey Pines, 11480 North Torrey Pines Road, La Jolla, CA 92037, United States. Speakers: David S. Kabakoff, Executive Partner and Partner at Sofinnova Venture Partners VIII.

Similar Private Companies By Industry

Company Name Region
Aritas Securities LLC United States
Chatham Capital Corp. United States
Broad Street Securities Inc. United States
Beal Advisors LLC United States
Resource Capital Markets, Inc. United States

Recent Private Companies Transactions

May 26, 2015
ConteXtream, Inc.
Private Placement
April 6, 2015
Natera, Inc.
Private Placement
April 6, 2015
Edge Therapeutics, Inc.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Sofinnova Ventures, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at